Ex Vivo and In Vitro Tissue Models: Applications Supporting an Early Indication of Therapeutic Outcome
About
Date/Time
September 29, 2023
Ex vivo and in vitro tissue models are continuing to emerge and grow as powerful scientific tools that can provide valuable insight into the function and behavior of complex biological systems. Highly customizable models can give companies the insight needed to develop and perfect antimicrobial formulations, implantable devices, and wound dressings. This is a beneficial tool in helping companies screen appropriate projects and helping healthcare practitioners to confidently make choices around products that are likely to be effective within clinical settings.
Tissue models can be used to study inflammation and biocompatibility, antimicrobial efficacy, and reepithelization. These techniques can aid in the production of a truly physiologically relevant skin construct for preclinical innovation.
Attendees of this webinar can expect to walk away with a better understanding of the following:
- The benefits and applications of in vitro and ex vivo models
- When to consider tissue models as an option
- Case Studies: proven solutions to demonstrate product efficacy or safety
Join NAMSA for this webinar as we discuss the latest advances in these models, how they can be applied to different therapeutic areas, and the customized support for your preclinical research.
*By registering for this event, you are providing NAMSA consent to contact you directly regarding NAMSA’s services. The information you are providing will be processed by NAMSA to better understand your product needs and interests. At any time, you can submit a request to withdraw your consent for the use of information provided by you by contacting us at: communications@namsa.com. For additional information, please visit our Privacy Policy or contact us at privacy@namsa.com.
NAMSA uses a third-party provider, GoToWebcast, to host NAMSA webinars. For information related to GoToWebcast’s privacy policy and utilization of information, please contact GoToWebcast directly.
Speaker
Hannah Thomas
Principal Senior ScientistHannah joined NAMSA in 2022 through the acquisition of Perfectus Biomed. She has been with Perfectus since 2013 and has held roles including Quality Manager, Operations Manager and became Principal Senior Scientist in 2021. During her time with the company, she has led the team to be the first in the world to develop and accredit biofilm test methods to ISO 17025, led collaborative projects to conduct groundbreaking research into wound care, and played a critical role in obtaining GLP accreditation. An integral part of the team with a breadth of knowledge and expertise in designing customized test methods that support MedTech product innovation.
Jessica Sanders
Commercial Senior ScientistJessica graduated from Duke University with a BS in Biology, she then went on to gain a MS in Microbiology from the University of Florida. Following this she spent seven years in education and science program development. Jessica has experience working in cosmetic testing and tissue R&D, and prior to joining Perfectus Biomed in 2021, she spent 3 years working in developing and managing customized and regulatory testing for medical devices and biologics.